England's Chief Medical Officer, Prof Sir Chris Whitty, has stated that relying on weight-loss drugs to tackle obesity would be a societal and medical failure.
According to Sir Chris, the drugs, such as Wegovy and Mounjaro, are "transformational" for people who need them, but this should be "a very small minority".
Sir Chris expressed concern that letting people become obese and then medicating them for life would be "shocking" and the "wrong answer" to one of the UK's most pressing health issues.
Obesity in the UK
Around two thirds of adults in the UK are overweight or obese, with the country's obesity levels soaring over the past three decades, while France has maintained relatively stable levels.
Sir Chris noted that the UK can learn from other countries, such as France, which have been more successful in promoting healthy eating and preventing obesity.
Weight-Loss Drugs
The NHS offers weight-loss drugs through specialist services, but there is also a significant private market, with an estimated 1.6 million people in the UK having tried weight-loss drugs in the past year.
Sir Chris warned that if a high proportion of the population ends up on these drugs, it would be a "societal failure", and instead emphasized the need to address the root causes of obesity.
Public Health Concerns
Sir Chris also criticized the marketing of junk food to children, which he believes drives obesity, and called for a reduction in the amount of fat and sugar in the UK's diet.
He argued that promoting healthy, tasty, and affordable food is possible, citing France as an example of a country that has successfully done so.
